Search
Search results
The Future Role of Cardio-oncologists
… mortality in developed countries; however, progress in the treatment of malignant diseases significantly improved … (38 %). 1 Within the last few decades the progress in the treatment of malignant diseases significantly improved … by adverse effects associated with intensive antitumorous treatment. In particular, cardiotoxicity may compromise the …
Type:
Article
Hypertension and Frailty Syndrome in Old Age: Current Perspectives
… resulting from ageing alongside multiple comorbidities, treatment of hypertension in elderly patients poses a significant challenge to treatment teams. Progressive disability with regard to the … isolation of the patient. It may also interfere with treatment adherence. Identifying causes of non-adherence to …
Type:
Article
Managing Heart Failure Patients with Multivessel Disease – Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention
… 1617 Likes: 0 Downloads: 2 Abstract The foundation of treatment for heart failure with reduced ejection fraction is guideline-directed medical treatment. However, surgical revascularisation offers … such as diabetes and hypertension. The foundation of treatment for HFrEF is guideline- directed medical treatment. …
Type:
Article
Bromocriptine for the Treatment of Peripartum Cardiomyopathy
… Figures & Tables References Article Bromocriptine for the Treatment of Peripartum Cardiomyopathy Tobias Koenig , Johann … prevented the onset of PPCM. Consequently, this treatment concept was transferred to and successfully used in … is to summarise this novel and disease-specific medical treatment, along with current knowledge on the epidemiology …
Type:
Article
Optimising Treatment of Heart Failure – Where are we Today?
… Video Optimising Treatment of Heart Failure - Where are we Today? Published: … Symposium - Experts on the Spot session titled 'Optimising treatment of heart failure - where are we today?' was … in acute heart failure (AHF) may help to address unmet treatment needs in acute heart failure (AHF) How to manage …
Type:
Video
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients
… Video ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients … 22 Oct 2018 Views: 11 Likes: 0 Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, …
Type:
Video
CONFIRM-HF – Targeting for Improvement in Exercise Capacity in Heart Failure
… effects. 24 One potential explanation of the neutral treatment effects on the outcomes could be due to the fact … the FAIR-HF (n=459) trial was performed and showed that treatment of HF patients with i.v FCM in patients with …
Type:
Article
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients
… Video ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients … 22 Oct 2018 Views: 95 Likes: 0 Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, …
Type:
Video
The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines
… a cytoprotective, anti-ischaemic agent established in the treatment of angina pectoris. In the 2012 European Society of Cardiology (ESC) guidelines for diagnosis and treatment of HF, ivabradine was recommended in symptomatic HF … are unchanged but trimetazidine is included for the treatment of angina pectoris with HF. This article discusses …
Type:
Article
Optimising Heart Failure Therapies in the Acute Setting
… (AHF) is a life-threatening condition requiring immediate treatment. The initial therapy should take into account the … and ethical issues should be integrated into the treatment plan at an early stage. The average survival of AHF … heart failure , cardiogenic shock , pathophysiology , treatment , precipitating factors , vulnerable phase , …
Type:
Article
